Trials / Recruiting
RecruitingNCT03396172
FreeDom: Innovative Strategy for the Management of COPD Exacerbations
FreeDom : Innovative Strategy for the Management of COPD Exacerbations Combining Early Hospitalisation Discharge, Automated Oxygen Weaning at Home, Telemedicine and Tele-rehabilitation
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Laval University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of the study is to assess the "FreeDom" innovative strategy (FreeO2 at Domicile) to reduce hospitalization duration in patients with COPD exacerbation. This strategy associates early hospital discharge, automated O2 flow weaning with FreeO2 system, telemedicine and tele-rehabilitation. The main hypothesis of this study is that the FreeDom strategy will reduce the number of hospitalization day by 50 percent at day 30.
Detailed description
The main objective of the study is to assess the "FreeDom" innovative strategy (FreeO2 at Domicile) to reduce hospitalization duration in patients with COPD exacerbation. This strategy will enable an early return home, patients using an innovative device that automatically adjusts and wean the oxygen flow (FreeO2 system) coupled to telemedicine and tele-rehabilitation. The main hypothesis of this study is that a strategy for an early return home with a home hospitalization managed by telemedicine will reduce the length of hospitalization by 50 percent from 30 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Control | The hospitalization will take place in the usual setting and the hospital discharge will be decided by pulmonologists according to the usual criteria |
| DEVICE | FreeDom | Early return home, patients using an innovative device that automatically adjusts and wean the oxygen flow (FreeO2 system) coupled to telemedicine and tele-rehabilitation |
Timeline
- Start date
- 2018-05-24
- Primary completion
- 2025-06-01
- Completion
- 2025-12-01
- First posted
- 2018-01-10
- Last updated
- 2024-06-18
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03396172. Inclusion in this directory is not an endorsement.